CADL Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Candel Therapeutics

Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

3 days ago - By: Candel Therapeutics - Mentions: TRIN

Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

12 days ago - By: Candel Therapeutics

Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors

12 days ago - By: Candel Therapeutics

Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors

a month ago - By: Stocktwits - Mentions: VTWG URTY

Candel Therapeutics Enters $130M Term Loan Facility To Advance Lead Product Candidate In Treatment Of Lung Cancer

3 months ago - By: The Motley Fool

Candel Reports 88 Percent Q2 Loss Drop

13 days ago - By: Candel Therapeutics

Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London

13 days ago - By: Candel Therapeutics

Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London

24 days ago - By: Benzinga - Mentions: VDC XLP TRIN ABT ...

EXCLUSIVE: Trinity Capital's New Loan Fuels Bobbie's Mission To Set New US Infant Nutrition Standards

a month ago - By: Candel Therapeutics

Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory Board

a month ago - By: Candel Therapeutics

Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory Board

a month ago - By: Benzinga - Mentions: BCRX XNCR SNTI ADAP ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

a month ago - By: Trinity Capital Inc. - Mentions: TRIN

Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer

a month ago - By: Candel Therapeutics

Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.

a month ago - By: Candel Therapeutics - Mentions: TRIN

Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.

a month ago - By: Candel Therapeutics

Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine

a month ago - By: Candel Therapeutics

Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine

a month ago - By: Candel Therapeutics

Candel Therapeutics to Present at the SITC 2025 Annual Meeting

a month ago - By: Candel Therapeutics

Candel Therapeutics to Present at the SITC 2025 Annual Meeting

2 months ago - By: Candel Therapeutics

Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025

2 months ago - By: Candel Therapeutics

Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025

2 months ago - By: Candel Therapeutics

Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025

2 months ago - By: Candel Therapeutics

Candel Therapeutics to Present Phase 3 Results of CAN-2409 in Localized Prostate Cancer at ASTRO 2025

2 months ago - By: Candel Therapeutics

Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board

2 months ago - By: Candel Therapeutics

Candel Therapeutics Appoints Renowned Immunotherapy Pioneer Carl H. June, M.D., to Research Advisory Board

3 months ago - By: Candel Therapeutics

Candel Therapeutics to Participate in Upcoming Investor Conferences in September

3 months ago - By: Candel Therapeutics

Candel Therapeutics to Participate in Upcoming Investor Conferences in September

3 months ago - By: Candel Therapeutics

Candel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

3 months ago - By: Candel Therapeutics

Candel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

4 months ago - By: Candel Therapeutics

Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference

4 months ago - By: Candel Therapeutics

Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer

4 months ago - By: Candel Therapeutics

Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer

4 months ago - By: Candel Therapeutics

Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution

4 months ago - By: Candel Therapeutics

Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution

5 months ago - By: Candel Therapeutics

Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock

5 months ago - By: Candel Therapeutics

CANDEL THERAPEUTICS INC (CADL) Stock News

CADL Latest News, Press Relases and Analysis